Advisory Board on Radiation and Worker Health (ABRWH), Subcommittee on Dose Reconstruction Review (SDRR), National Institute for Occupational Safety and Health (NIOSH), 21738-21739 [2021-08428]
Download as PDF
<![CDATA[
21738
Federal Register / Vol. 86, No. 77 / Friday, April 23, 2021 / Notices
the same or similar items and other
references (including contract numbers,
points of contact with telephone
numbers and other relevant
information).
Postaward. For responses in the
Contractor Performance Assessment
Reporting System (CPARS).
• FAR 42.1503(d). Requires
contractors be afforded up to 14
calendar days from the notification date
that a past performance evaluation has
been entered into CPARS to submit
comments, rebutting statements, or
additional information. Past
performance information is relevant
information regarding a contractor’s
actions under previously awarded
contracts or orders, for future source
selection purposes. Source selection
officials may obtain past performance
information from a variety of sources.
The contracting officer will use the
information to support future source
selection decisions.
khammond on DSKJM1Z7X2PROD with NOTICES
C. Annual Burden
Respondents: 65,373.
Total Annual Responses: 83,262.
Total Burden Hours: 166,524.
18:15 Apr 22, 2021
Jkt 253001
Janet Fry,
Director, Federal Acquisition Policy Division,
Office of Governmentwide Acquisition Policy,
Office of Acquisition Policy, Office of
Governmentwide Policy.
[FR Doc. 2021–08409 Filed 4–22–21; 8:45 am]
BILLING CODE 6820–EP–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Board on Radiation and
Worker Health (ABRWH),
Subcommittee on Dose
Reconstruction Review (SDRR),
National Institute for Occupational
Safety and Health (NIOSH)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
D. Public Comment
A 60-day notice was published in the
Federal Register at 86 FR 8913, on
February 10, 2021. One respondent
submitted comments; however, they did
not change the estimate of the burden.
Comment: The commenter expressed
there is a need for a revision to the
practices of acquiring, analyzing, and
utilizing past performance information
for source selection in federal
acquisitions. The commenter noted that
‘‘there have emerged in recent years a
number of issues that result in a
misleading, incomplete, deceptive, or
distorted assessment of an Offeror’s Past
Performance that is not allowing fair
competition for contracts which
evaluate this factor.’’ The commenter
suggested changes on a few areas by
using examples.
Response: Some of the suggestions
made by the commenter may require
consideration via the rulemaking
process, and other suggestions refer to
practices by particular agencies. These
suggestions are outside the scope of this
information collection renewal. The
commenter did not express an opinion
on whether the collections of
information are needed; whether the
estimated number of burden hours is
accurate; or ways to minimize the
burden of the collection of information.
Therefore, the estimate of the burden
was not changed.
Obtaining Copies: Requesters may
obtain a copy of the information
VerDate Sep<11>2014
collection documents from the GSA
Regulatory Secretariat Division by
calling 202–501–4755 or emailing
GSARegSec@gsa.gov. Please cite OMB
Control No. 9000–0142, Past
Performance Information.
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
for the Subcommittee for Dose
Reconstruction Reviews (SDRR) of the
Advisory Board on Radiation and
Worker Health (ABRWH). This meeting
is open to the public, but without a
public comment period. The public is
welcome to submit written comments in
advance of the meeting, to the contact
person below. Written comments
received in advance of the meeting will
be included in the official record of the
meeting. The public is also welcomed to
listen to the meeting by joining the
audio conference (information below).
The audio conference line has 150 ports
for callers.
DATES: The meeting will be held on June
16, 2021, from 10:30 a.m. to 2:30 p.m.,
EDT. Written comments must be
received on or before June 9, 2021.
ADDRESSES: You may submit comments
by mail to: Sherri Diana, National
Institute for Occupational Safety and
Health, 1090 Tusculum Avenue, MS C–
34, Cincinnati, Ohio 45226.
Meeting Information: Audio
Conference Call via FTS Conferencing.
The USA toll-free dial-in number is 1–
866–659–0537; the pass code is
9933701.
SUMMARY:
FOR FURTHER INFORMATION CONTACT:
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
Rashaun Roberts, Ph.D., Designated
Federal Officer, NIOSH, CDC, 1090
Tusculum Avenue, Mailstop C–24,
Cincinnati, Ohio 45226, Telephone:
(513) 533–6800, Toll Free 1(800)CDC–
INFO, Email: ocas@cdc.gov.
SUPPLEMENTARY INFORMATION:
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation
Program Act of 2000 to advise the
President on a variety of policy and
technical functions required to
implement and effectively manage the
new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines that
have been promulgated by the
Department of Health and Human
Services (HHS) as a final rule; advice on
methods of dose reconstruction, which
have also been promulgated by HHS as
a final rule; advice on the scientific
validity and quality of dose estimation
and reconstruction efforts being
performed for purposes of the
compensation program; and advice on
petitions to add classes of workers to the
Special Exposure Cohort (SEC). In
December 2000, the President delegated
responsibility for funding, staffing, and
operating the Advisory Board to HHS,
which subsequently delegated this
authority to CDC. NIOSH implements
this responsibility for CDC.
The Advisory Board’s charter was
issued on August 3, 2001, renewed at
appropriate intervals, rechartered on
March 22, 2020, and will terminate on
March 22, 2022.
Purpose: The Advisory Board is
charged with (a) providing advice to the
Secretary, HHS, on the development of
guidelines under Executive Order
13179; (b) providing advice to the
Secretary, HHS, on the scientific
validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advise the Secretary on
whether there is a class of employees at
any Department of Energy facility who
were exposed to radiation but for whom
it is not feasible to estimate their
radiation dose, and on whether there is
reasonable likelihood that such
radiation doses may have endangered
the health of members of this class.
SDRR was established to aid the
Advisory Board in carrying out its duty
to advise the Secretary, HHS, on dose
reconstruction.
Matters To Be Considered: The agenda
will include discussions on the
following dose reconstruction program
quality management and assurance
activities: Dose reconstruction cases
E:\FR\FM\23APN1.SGM
23APN1
Federal Register / Vol. 86, No. 77 / Friday, April 23, 2021 / Notices
under review from Set 29, possibly
including cases involving: Albuquerque
Operations Office, Area IV of the Santa
Susana Field Laboratory, Argonne
National Laboratory-East, Argonne
National Laboratory-West, Battelle
Laboratories-King Avenue, Clarksville
Modification Center, Feed Materials
Production Center (FMPC), Fermi
National Accelerator Laboratory,
General Atomics, Hanford, Idaho
National Laboratory, Lawrence Berkeley
National Laboratory, Lawrence
Livermore National Laboratory, Los
Alamos National Laboratory, Mound
Plant, Nevada Test Site, Oak Ridge
Gaseous Diffusion Plant (K–25), Oak
Ridge Institute for Science Education,
Oak Ridge National Laboratory (X–10),
Pacific Northwest National Laboratory,
Paducah Gaseous Diffusion Plant,
Pantex Plant, Portsmouth Gaseous
Diffusion Plant, Rocky Flats Plant,
Savannah River Site, and/or Y–12 Plant.
Agenda items are subject to change as
priorities dictate.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2021–08428 Filed 4–22–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Mine Safety and Health Research
Advisory Committee (MSHRAC)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
AGENCY:
ACTION:
Notice of meeting.
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
for the Mine Safety and Health Research
Advisory Committee (MSHRAC). This is
a virtual meeting. It is open to the
public, limited only by web conference
lines (500 web conference lines are
available).
khammond on DSKJM1Z7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
18:15 Apr 22, 2021
Jkt 253001
The meeting will be held on June
21, 2021, from 10:00 a.m. to 2:30 p.m.,
EDT.
DATES:
If you wish to attend the
virtual meeting, please contact Ms.
Berni Metzger by email at metzger@
cdc.gov or by telephone at (412) 386–
4541 at least 5 business days in advance
of the meeting. She will provide you
with the Zoom web conference access
information.
ADDRESSES:
FOR FURTHER INFORMATION CONTACT:
George W. Luxbacher, Designated
Federal Officer, MSHRAC, National
Institute for Occupational Safety and
Health (NIOSH), CDC, 2400 Century
Parkway NE, Atlanta, GA 30345,
Telephone: (404) 498–2808; Email:
gluxbacher@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: This committee is charged
with providing advice to the Secretary,
Department of Health and Human
Services; the Director, CDC; and the
Director, NIOSH, on priorities in mine
safety and health research, including
grants and contracts for such research,
30 U.S.C. 812(b)(2), Section 102(b)(2).
Matters To Be Considered: The
agenda will include discussions on
NIOSH mining safety and health
research capabilities, projects, and
outcomes, including FY21 new mining
projects; updates on MINER Act
extramural research; and current
intramural dust, diesel particulate
matter (DPM) and silica research. The
meeting will also include an update
from the NIOSH Associate Director for
Mining. Agenda items are subject to
change as priorities dictate.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2021–08429 Filed 4–22–21; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
21739
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS–10500]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Centers for Medicare &
Medicaid Services, Health and Human
Services (HHS).
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995 (the
PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information (including each proposed
extension or reinstatement of an existing
collection of information) and to allow
60 days for public comment on the
proposed action. Interested persons are
invited to send comments regarding our
burden estimates or any other aspect of
this collection of information, including
the necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions,
the accuracy of the estimated burden,
ways to enhance the quality, utility, and
clarity of the information to be
collected, and the use of automated
collection techniques or other forms of
information technology to minimize the
information collection burden.
DATES: Comments must be received by
June 22, 2021.
ADDRESSES: When commenting, please
reference the document identifier or
OMB control number. To be assured
consideration, comments and
recommendations must be submitted in
any one of the following ways:
1. Electronically. You may send your
comments electronically to https://
www.regulations.gov. Follow the
instructions for ‘‘Comment or
Submission’’ or ‘‘More Search Options’’
to find the information collection
document(s) that are accepting
comments.
2. By regular mail. You may mail
written comments to the following
address: CMS, Office of Strategic
Operations and Regulatory Affairs,
Division of Regulations Development,
Attention: Document Identifier/OMB
Control Number: CMS–P–0015A, Room
C4–26–05, 7500 Security Boulevard,
Baltimore, Maryland 21244–1850.
SUMMARY:
E:\FR\FM\23APN1.SGM
23APN1
]]>Agencies
[Federal Register Volume 86, Number 77 (Friday, April 23, 2021)]
[Notices]
[Pages 21738-21739]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-08428]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Board on Radiation and Worker Health (ABRWH),
Subcommittee on Dose Reconstruction Review (SDRR), National Institute
for Occupational Safety and Health (NIOSH)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC
announces the following meeting for the Subcommittee for Dose
Reconstruction Reviews (SDRR) of the Advisory Board on Radiation and
Worker Health (ABRWH). This meeting is open to the public, but without
a public comment period. The public is welcome to submit written
comments in advance of the meeting, to the contact person below.
Written comments received in advance of the meeting will be included in
the official record of the meeting. The public is also welcomed to
listen to the meeting by joining the audio conference (information
below). The audio conference line has 150 ports for callers.
DATES: The meeting will be held on June 16, 2021, from 10:30 a.m. to
2:30 p.m., EDT. Written comments must be received on or before June 9,
2021.
ADDRESSES: You may submit comments by mail to: Sherri Diana, National
Institute for Occupational Safety and Health, 1090 Tusculum Avenue, MS
C-34, Cincinnati, Ohio 45226.
Meeting Information: Audio Conference Call via FTS Conferencing.
The USA toll-free dial-in number is 1-866-659-0537; the pass code is
9933701.
FOR FURTHER INFORMATION CONTACT:
Rashaun Roberts, Ph.D., Designated Federal Officer, NIOSH, CDC,
1090 Tusculum Avenue, Mailstop C-24, Cincinnati, Ohio 45226, Telephone:
(513) 533-6800, Toll Free 1(800)CDC-INFO, Email: [email protected].
SUPPLEMENTARY INFORMATION:
Background: The Advisory Board was established under the Energy
Employees Occupational Illness Compensation Program Act of 2000 to
advise the President on a variety of policy and technical functions
required to implement and effectively manage the new compensation
program. Key functions of the Advisory Board include providing advice
on the development of probability of causation guidelines that have
been promulgated by the Department of Health and Human Services (HHS)
as a final rule; advice on methods of dose reconstruction, which have
also been promulgated by HHS as a final rule; advice on the scientific
validity and quality of dose estimation and reconstruction efforts
being performed for purposes of the compensation program; and advice on
petitions to add classes of workers to the Special Exposure Cohort
(SEC). In December 2000, the President delegated responsibility for
funding, staffing, and operating the Advisory Board to HHS, which
subsequently delegated this authority to CDC. NIOSH implements this
responsibility for CDC.
The Advisory Board's charter was issued on August 3, 2001, renewed
at appropriate intervals, rechartered on March 22, 2020, and will
terminate on March 22, 2022.
Purpose: The Advisory Board is charged with (a) providing advice to
the Secretary, HHS, on the development of guidelines under Executive
Order 13179; (b) providing advice to the Secretary, HHS, on the
scientific validity and quality of dose reconstruction efforts
performed for this program; and (c) upon request by the Secretary, HHS,
advise the Secretary on whether there is a class of employees at any
Department of Energy facility who were exposed to radiation but for
whom it is not feasible to estimate their radiation dose, and on
whether there is reasonable likelihood that such radiation doses may
have endangered the health of members of this class. SDRR was
established to aid the Advisory Board in carrying out its duty to
advise the Secretary, HHS, on dose reconstruction.
Matters To Be Considered: The agenda will include discussions on
the following dose reconstruction program quality management and
assurance activities: Dose reconstruction cases
[[Page 21739]]
under review from Set 29, possibly including cases involving:
Albuquerque Operations Office, Area IV of the Santa Susana Field
Laboratory, Argonne National Laboratory-East, Argonne National
Laboratory-West, Battelle Laboratories-King Avenue, Clarksville
Modification Center, Feed Materials Production Center (FMPC), Fermi
National Accelerator Laboratory, General Atomics, Hanford, Idaho
National Laboratory, Lawrence Berkeley National Laboratory, Lawrence
Livermore National Laboratory, Los Alamos National Laboratory, Mound
Plant, Nevada Test Site, Oak Ridge Gaseous Diffusion Plant (K-25), Oak
Ridge Institute for Science Education, Oak Ridge National Laboratory
(X-10), Pacific Northwest National Laboratory, Paducah Gaseous
Diffusion Plant, Pantex Plant, Portsmouth Gaseous Diffusion Plant,
Rocky Flats Plant, Savannah River Site, and/or Y-12 Plant. Agenda items
are subject to change as priorities dictate.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2021-08428 Filed 4-22-21; 8:45 am]
BILLING CODE 4163-18-P
